Journal article
Antithrombotic therapy in the management of hospitalised patients with COVID-19
Abstract
Hospitalised patients with coronavirus disease 2019 (COVID-19) are at a significantly higher risk of having thromboembolic events while in hospital and in the immediate post-hospital discharge period. Based on early data from observational studies, multiple high quality randomised controlled trials have been conducted worldwide to evaluate optimal thromboprophylaxis regimens to reduce thromboembolism and other COVID-19-related adverse outcomes …
Authors
Koulas I; Goldin M; Schulman S; Spyropoulos AC
Journal
British Journal of Hospital Medicine, Vol. 84, No. 5, pp. 1–11
Publisher
Mark Allen Group
Publication Date
May 2, 2023
DOI
10.12968/hmed.2022.0519
ISSN
1750-8460